GlassScriptPhysician profile
Michael S Korey
NPI 1497792410
$3,276.75
in general payments reported to CMS, 2019-2025
23 companies · $720 in 2025
The $720 reported for 2025 was more than what a typical Ophthalmology provider received nationally (typical 2025 total: $384).
Payments by year
General payments by program year, as reported to CMS.
General payments by year: 2019: $583 · 2020: $224 · 2021: $636 · 2022: $321 · 2023: $352 · 2024: $441 · 2025: $720.
What the payments were for
Nature of payment as categorized by the reporting companies: meals, consulting, travel, and so on.
Food and Beverage: $1,512.
View as a table
| Payment type | Amount (2023-2025) |
|---|---|
| Food and Beverage | $1,512.42 |
Payment-type detail covers 2023-2025; earlier years are included in totals but not broken out here.
Who reported paying
General payments only, as reported to CMS. Product names cover 2023-2025.
| Company | General payments | Years | Top products |
|---|---|---|---|
| Abbvie INC. | $828.04 | 2022-2025 | |
| Aerie Pharmaceuticals, INC. | $495.11 | 2019-2021 | |
| Alcon Vision LLC | $476.26 | 2021-2025 | Rocklatan, Hydrus Microstent |
| Allergan, INC. | $317.46 | 2019-2021 | |
| Novartis Pharmaceuticals Corporation | $180.63 | 2019-2022 | |
| New World Medical,INC. | $132.09 | 2019 | |
| Mallinckrodt Hospital Products INC. | $112.39 | 2023-2025 | Acthar |
| Bausch & Lomb, A Division of Bausch Health US, LLC | $110.70 | 2019-2021 | |
| Sun Pharmaceutical Industries INC. | $90.27 | 2019-2022 | |
| Bausch & Lomb Americas INC. | $74.75 | 2022-2025 | Miebo, Vyzulta, Lotemax Sm |
| Thea Pharma INC. | $67.66 | 2023-2025 | Iyuzeh |
| Sight Sciences, INC. | $65.76 | 2023-2024 | Omni Surgical System |
| Tarsus Pharmaceuticals, INC. | $51.98 | 2024-2025 | Xdemvy |
| Apellis Pharmaceuticals, INC. | $49.08 | 2022-2023 | Syfovre |
| Glaukos Corporation | $47.17 | 2025 | Istent Infinite |
Show all 23 companies
| Company | General payments | Years | Top products |
|---|---|---|---|
| Harrow Eye, LLC | $32.26 | 2024 | Vevye |
| Rayner Intraocular Lenses Limited | $27.95 | 2024 | Rayone Spheric, Rayone Emv, Rayner Cataract Set 1 |
| Akorn Operating Company LLC | $22.83 | 2021 | |
| Shire North American Group INC | $21.65 | 2019 | |
| Rxsight INC | $19.55 | 2023 | Rxsight Injector Handpiece, Rxsight Light Delivery Device (Ldd), Rxsight Light Adjustable Lens (Rxlal) |
| Astellas Pharma US INC | $19.18 | 2025 | Izervay |
| Kala Pharmaceuticals, INC. | $18.83 | 2019 | |
| Ocular Therapeutix, INC. | $15.15 | 2024 | Dextenza |
Drugs and devices associated with these payments
CMS records which products a payment was associated with, not how the money was allocated. Association is not allocation: one payment can be associated with several products, and a product listing does not mean the payment was made because of that product. Product detail covers 2023-2025.
If you want to bring it up
Most clinicians are glad to talk about this. A respectful way in:
- "I saw Michael Korey listed in the CMS Open Payments database. Can you tell me about your work with those companies?"
- "Is there a generic or alternative to this medication, and would it work as well for me?"
- "What made you choose this particular treatment for my situation?"
These are normal questions. A good clinician will welcome them.
Share this page
Keep an eye on this page
Get an email when the next June refresh changes this page. No account needed.
Source: CMS Open Payments, program years 2019-2025, as reported to CMS by drug and device makers (published June 30, 2026). Drug and device detail covers 2023-2025.